Frier Levitt attorneys recently reversed roughly ninety-six percent (96%) of the audit findings issued by a major PBM against a Georgia-based pharmacy. With the help of Frier Levitt’s guidance, the Pharmacy compiled supporting documentation that... Read More
Medical spas are regulated by a patchwork of state rules and regulations usually governed by a medical board. In addition to standards and protocols regarding delegation/supervision of non-physicians such as physician-assistants, nurse practitioners... Read More
The pharmacy benefits landscape is changing for large employer groups and affecting all parties in the drug supply chain. Recent federal actions, such as the Federal Trade Commission’s investigation into Pharmacy Benefit Managers (“PBMs”)... Read More
Frier Levitt attorney Dr. Lawrence F. Kobak, DPM, Esq., published an article, “Closure of a Podiatric Practice” in the November/December 2023 issue of Podiatry Management. The article discusses common concerns podiatrists face when closing a... Read More
On November 1, 2023, a bipartisan group of senators announced that they had reintroduced legislation to expand and eliminate barriers to treat opioid use disorder (OUD) through telehealth. Specifically, the Telehealth Response for E-prescribing... Read More
This summer, the Office for Civil Rights (OCR) and the Federal Trade Commission (FTC) issued and published warnings to over 120 hospitals and telehealth providers regarding third-party online tracking technologies that may be integrated into their... Read More
On October 3rd, 2023, the U.S. Food and Drug Administration (FDA) published a proposed rule to clarify and confirm that in vitro diagnostic products (IVDs), including certain laboratory developed tests (LDTs), are considered devices under the... Read More
On November 15, 2023, Frier Levitt attorneys Dae Lee, Harini Bupathi, and Adam Farkas hosted a comprehensive webinar delving into the most common issues pharmacies faced when audited by Pharmacy Benefit Managers (“PBMs”) in 2023, and what... Read More
Employers and unions say the PBMs are favoring costlier drugs over less expensive options and aren’t open about their rebates. Employers and unions are growing increasingly frustrated with rising costs from pharmacy-benefit managers (PBMs) tasked... Read More
Frier Levitt successfully reversed findings issued by the State Department of Health against a South Carolina-based pharmacy. After an audit, the State asserted allegations of controlled substance record-keeping violations against the pharmacy.... Read More
